Helicobacter pylori drug resistance presents a significant challenge to the successful
eradication of this pathogen. To find strategies to improve the eradication efficacy of H …

In view of the relentless increase in antibiotic resistance in human pathogens, efforts are
needed to safeguard our future therapeutic options against infectious diseases. In addition …

Significant progress has been obtained since the III Brazilian Consensus Conference on H.
pylori infection held in 2012, in Bento Gonçalves, Brazil, and justify a fourth meeting to …

INTRODUCTION: Antibiotic resistance is the main factor that affects the efficacy of current
therapeutic regimens against Helicobacter pylori. This study aimed to determine the rates of …

Background Helicobacter pylori has a worldwide distribution and is associated with the
pathogenesis of various diseases of the digestive system. Treatment to eradicate this …

Abstract Background The prevalence of Helicobacter pylori antibiotic susceptibility in the
Nepalese strains is untracked. We determined the antibiotic susceptibility for H. pylori and …

In developing countries, clarithromycin resistance and frequency of re-infection are factors
that contribute to high prevalence of Helicobacter pylori infection. The aim of this research …

Evaluation of Helicobacter pylori resistance to antibiotics is crucial for treatment strategy in
Myanmar. Moreover, the genetic mechanisms involved remain unknown. We aimed to …

This review summarizes important studies regarding H. pylori therapy published from April
2013 to April 2014. The main themes that emerge are assessing the efficacy of standard …

This study aimed to investigate the clarithromycin resistance and its associated molecular
mechanisms among Helicobacter pylori isolates from dyspeptic patients in Shiraz, Iran. From …